Zemdri (plazomicin) 500 mg/10mL
Plazomicin · INJECTION · Cipla Therapeutics Inc.
No Recall History
Plain English
Zemdri (plazomicin) is a injection containing plazomicin at 500 mg/10mL, taken intravenous. Manufactured by Cipla Therapeutics Inc..
Key Facts
- Brand Name
- Zemdri (plazomicin)
- Generic Name
- Plazomicin
- NDC Code (Product)
80735-820- Manufacturer
- Cipla Therapeutics Inc.
- Strength
- 500 mg/10mL
- Dosage Form
- INJECTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- NDA210303
- Marketing Start
- 07/16/2018
Recall History
No Recall HistoryFrequently Asked Questions
What is Zemdri (plazomicin) used for?
Zemdri (plazomicin) contains Plazomicin. It is a injection taken intravenous. Consult your doctor for specific uses.
Is Zemdri (plazomicin) a controlled substance?
Zemdri (plazomicin) is not classified as a controlled substance by the DEA.
What is the generic name for Zemdri (plazomicin)?
The generic name for Zemdri (plazomicin) is Plazomicin. There are no other listed brand versions of Plazomicin.
What is the NDC code for Zemdri (plazomicin) 500 mg/10mL?
The NDC (National Drug Code) for Zemdri (plazomicin) 500 mg/10mL is 80735-820, listed by Cipla Therapeutics Inc..
Other Zemdri (plazomicin) Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)